Goldman Sachs raised the firm’s price target on Edwards Lifesciences (EW) to $104 from $94 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EW:
- Edwards Lifesciences price target raised to $90 from $85 at UBS
- Edwards Lifesciences price target raised to $84 from $81 at Canaccord
- Edwards Lifesciences upgraded to Outperform at Raymond James
- Edwards Lifesciences Reports Strong Earnings and Growth
- Edwards Lifesciences price target raised to $92 from $88 at Evercore ISI